Characterization of liver function tests (LFTs) following tebentafusp (tebe) in previously treated (2L+) metastatic uveal melanoma (mUM) patients (pts) Meeting Abstract


Authors: Sato, T.; Carvajal, R. D.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L. F.; Nathan, P.; Rioth, M.; Hamid, O.; Piulats, J. M.; Luke, J. J.; Johnson, D. B.; Leyvraz, S.; Espinosa, E.; Abdullah, S. E.; Sum, D.; Lockwood, S.; Mendez, P.; Butler, M. O.
Abstract Title: Characterization of liver function tests (LFTs) following tebentafusp (tebe) in previously treated (2L+) metastatic uveal melanoma (mUM) patients (pts)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120305194
DOI: 10.1200/JCO.2021.39.15_suppl.e21513
PROVIDER: wos
Notes: Meeting Abstract: e21513 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors